Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

Share Price is delayed by 15 minutes
Get Live Data
84.00    0.00 (0.00%)
Bid:
83.60
Ask:
85.90
Spread: 2.30 (2.751%)
Market Cap: £235.37m
ESNT Live PriceLast checked at - London Stock Exchange

Intraday Essentra Share Chart

Director/PDMR Shareholding

7 Apr 2026 07:00

RNS Number : 3527Z
Essentra plc
07 April 2026
 

Essentra plc

Directors/Persons Discharging Managerial Responsibility (PDMR)

Notification and public disclosure of transactions by PDMRs

 

The notification below, is made on behalf of PDMRs under article 19.1 of the Market Abuse Regulation ('MAR') and in accordance with Article 19.3 of MAR.

On 31 March 2026, the Company granted Long-Term Incentive Plan (LTIP) awards to PDMRs as set out below. The performance period is three years with a further two- year holding for the Executive Directors, Scott Fawcett and Rowan Baker.

On 31 March 2026. awards under the Deferred Annual Share Bonus (DASB) Plan were also made. These awards normally vest after three years subject to continued service.

The share price used to calculate the number of shares was 90.1p (closing share price at 30 March 2026).

Employee Name

No. of shares 2026 LTIP

No. of shares 2025 DASB

Total shares

Scott Fawcett

Chief Executive Officer

958,381

81,463

1,039,844

Rowan Baker

Chief Financial Officer

732,520

62,265

794,785

Sam Edwards

Chief Digital Information Officer

220,106

9,171

229,277

Richard David Sederman

MD, APAC

198,371

6,918

205,289

Chris Brooks

MD Americas

401,513

8,490

410,003

Shaun Laubscher

Chief People Officer

252,831

0

252,831

Total

 

 

2,932,029

 

1

 

Further details applying to all PDMRs:

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Essentra plc

b)

 

LEI

 

5493007MOZNA03BVNE96

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

a)

 

Description of the financial instrument, type of instrument

Ordinary 25p shares

Identification code

GB00B0744359

b)

 

Nature of the transaction

 

Grant of awards under the Essentra plc 2024 Long Term Incentive Plan and the Deferred Annual Share Bonus Plan.

 

c)

Price(s) and volume(s)

Volume

Price (p)

2,932,029

Nil

d)

 

Aggregated information

- Aggregated volume

- Aggregated Price

As above.

e)

 

Date of the transaction

 

 

07 April 2026

f)

 

Place of the transaction

London Stock Exchange (XLON)

For further enquiries, please contact

Essentra plc

Tim George

Deputy Company Secretary

T: + 44 (0) 1908 359100

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUCACUPQGUQ
Date   Source Headline
10th Jun 20269:47 amRNSHolding(s) in Company
1st Jun 20267:00 amRNSTotal Voting Rights
29th May 20262:32 pmRNSTransaction in Own Shares
21st May 202610:55 amRNSResult of AGM
20th May 20267:00 amRNSAcquisition of Boteco Srl
20th May 20267:00 amRNS2026 AGM Trading Update
14th May 20265:15 pmRNSDirector/PDMR Shareholding
12th May 20267:03 amRNSTransaction in Own Shares
1st May 202612:17 pmRNSTotal Voting Rights
29th Apr 20268:12 amRNSTransaction in Own Shares
28th Apr 20263:25 pmRNSDirector/PDMR Shareholding
24th Apr 20263:30 pmRNSDirector/PDMR Shareholding
22nd Apr 20268:15 amRNSTransaction in Own Shares
21st Apr 20264:09 pmRNSDirector/PDMR Shareholding
17th Apr 20267:52 amRNSHolding(s) in Company
15th Apr 202610:06 amRNSDirector/PDMR Shareholding
15th Apr 20268:24 amRNSTransaction in Own Shares
15th Apr 20268:18 amRNSHolding(s) in Company
9th Apr 20268:24 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSHolding(s) in Company
1st Apr 20264:45 pmRNSDirector/PDMR Shareholding
1st Apr 20263:21 pmRNSDirector/PDMR Shareholding
1st Apr 20263:15 pmRNSTransaction in Own Shares
1st Apr 20263:08 pmRNSTotal Voting Rights
30th Mar 20262:00 pmRNSAnnual Financial Report
24th Mar 202610:05 amRNSTransaction in Own Shares
24th Mar 20268:17 amRNSHolding(s) in Company
19th Mar 20268:43 amRNSDirector/PDMR Shareholding
17th Mar 20261:41 pmRNSDirector/PDMR Shareholding
17th Mar 202610:30 amRNSDirectorate change
17th Mar 202610:28 amRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSResults for the Full Year Ended 31 December 2025
17th Mar 20267:00 amRNSResults for the Full Year Ended 31 December 2025
16th Mar 20269:40 amRNSTransaction in Own Shares
16th Mar 20269:40 amRNSTransaction in Own Shares
13th Mar 202612:00 pmRNSCompany Secretary Change
9th Mar 20269:00 amRNSNotice of Full Year 2025 Results
9th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTotal Voting Rights
26th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:58 amRNSHolding(s) in Company
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 202612:20 pmRNSHolding(s) in Company
17th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.